The content on this site is intended for healthcare professionals only
Dr George Follows speaks with ecancertv at BSH 2016 about the UK CLL session he chaired, reviewing the data presented, the background, and potential clinical applications of current research.
Looking forward to patient impacts, he describes drugs currently moving through trial phases and approaching wider release.
For an introduction to the tumour microenvironment, you can view more from Dr Follows here.
For more from Dr Jan Burger, you can watch his interview with ecancertv here.
For more from Dr Stephen Mulligan, you can watch his interview with ecancertv here.
ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Multiple myeloma In Rwanda: The need for further research
EHA 2024: Multiple myeloma roundup
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for August 25th - 31st, 2023
The current status of multiple myeloma diagnosis and treatment
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
